¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-30
±³À°ÀÏÀÚ : 2023-06-30
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï ÄÚ¿¢½º B1 ´ÙÀ̾Ƹóµå·ë

±³À°ÁÖÁ¦ : Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187  

À̸ÞÀÏ : ksimd2014@naver.com

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 45ºÐ

¼¼ºÎ¼ö°­·á : 70,000¿ø  

ºñ°í »çÀüµî·Ï(ȸ   ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø»çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ6¸¸¿ø            ÇöÀåµî·Ï(ȸ   ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿øÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:00~10:40 Challenges and future scope of exosomes in the treatment of intractable diseases including IMD Á¶½Ö±¸(°Ç±¹ÀÇ´ë)

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:40~11:20 Research journey of elucidation of pathophysiology and therapeutic strategy focusing on Krabbe disease and I-cell disease Norio Sakai( )

ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:20~11:30 Break Time ( )

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:30~12:00 Experience in prenatal diagnosis and counseling of IMD À¯ÀºÁ¤(Â÷ÀÇ´ë)

½Ä»ç 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 12:00~13:00 ½Ä»ç ( )

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:00~13:25 Newborn screening of IMD by whole genome sequencing: opportunities and challenges ±ââ¼®(GCÁö³ð)

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:25~13:50 Screening newborns for IMD based on NeoSeq (Update) ¼º¹®¿ì(¼­¿ïÀÇ´ë)

±âŸ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:50~14:50 oral presentation ( )

ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:50~15:10 Break Time & Poster rounding ( )

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:10~15:35 Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care Á¶¼ºÀ±(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:35~16:00 How to detect late-onset IMD in patients with movement disorders ÀÌÀçÇõ(ºÎ»êÀÇ´ë)

ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:00~16:10 Break Time ( )

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:10~16:35 Therapeutic unmet needs in Fabry disease and the underlying mechanisms À̹üÈñ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:35~17:00 Unravelling pathophysiology of Mucopolysaccharidosis type II using cerebral organoid ÀüÁ¾±Ù(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 17:00~17:25 Modeling of IMD using patient-specific induced pluripotent stem cells ÀÌÀçö(¼º±Õ°ü¾à´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 °¡Å縯 È£Èí±â ¿¬¼ö°­Á : 2023-07-01
´ÙÀ½±Û ÀÏ»ê¹éº´¿ø Àå±âÀÌ½Ä ½ÉÆ÷Áö¾ö : 2023-06-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20820 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦31ȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­Á : 2024-06-16 0 5 2024-05-27
20819 ºÎ»ê ´ëÇÑÀ̽ÄÇÐȸ 2024³â ½ÅÀåÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-16 0 3 2024-05-27
20818 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-16 0 4 2024-05-27
20817 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ¾ð¾î°Ë»ç ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-06-16 0 3 2024-05-27
20816 ¼­¿ï Á¦28ȸ ¼­¿ï½Ã³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Çмú´ëȸ : 2024-06-16 0 10 2024-05-27
20815 ¼­¿ï 2024³â Á¦16ȸ °æÈñ´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-16 0 15 2024-05-27
20814 ºÎ»ê 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿µ³²¼Ò¾Æ¾Ë·¹¸£±â ½ÉÆ÷Áö¿ò : 2024-06-16 0 3 2024-05-27
20813 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦23Â÷ ½Å»ý¾Æ¼Ò»ý¼ú workshop : 2024-06-16 0 12 2024-05-27
20812 ¼­¿ï 2024³â ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÀÇÇÐÀ¯ÀüÇÐ Primer Course : 2024-06-16 0 13 2024-05-27
20811 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 12 2024-05-27
20810 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú ÄÄÇ»Åͼö¼úÇÐȸ - Á¦3ȸ ±¹Á¦ ·Îº¿¼ö¼ú ½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
20809 °æ±â ´ëÇѺñ¸¸ÇÐȸ Á¦18ȸ ODOT (One Day Course of Obesity Treatment) : 2024-06-15 0 4 2024-05-27
20808 ¼­¿ï 2024³â Á¦ 1ȸ ºñ¸¸ ¿¬¼ö°­ÁÂ(ObesityCare Pro) : 2024-06-15 0 4 2024-05-27
20807 ¼­¿ï 2024 °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 3 2024-05-27
20806 ¼­¿ï ´ëÇѼöºÎ¿Ü°úÇÐȸ ¼öºÎ»óÁö ÇÏ°èÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷